Amicus Therapeutics, Inc. (DELISTED) (FOLD:DL)
14.49
0.00 (0.00%)
USD |
NASDAQ |
May 07, 16:00
Amicus Therapeutics Total Assets (Quarterly) : 949.87M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 949.87M |
| September 30, 2025 | 868.81M |
| June 30, 2025 | 815.30M |
| March 31, 2025 | 789.84M |
| December 31, 2024 | 785.03M |
| September 30, 2024 | 786.56M |
| June 30, 2024 | 749.48M |
| March 31, 2024 | 721.79M |
| December 31, 2023 | 777.88M |
| September 30, 2023 | 764.08M |
| June 30, 2023 | 730.09M |
| March 31, 2023 | 700.52M |
| December 31, 2022 | 724.17M |
| September 30, 2022 | 759.53M |
| June 30, 2022 | 800.59M |
| March 31, 2022 | 826.94M |
| December 31, 2021 | 905.14M |
| September 30, 2021 | 956.68M |
| June 30, 2021 | 786.89M |
| March 31, 2021 | 810.03M |
| December 31, 2020 | 886.52M |
| September 30, 2020 | 900.54M |
| June 30, 2020 | 701.45M |
| March 31, 2020 | 738.35M |
| December 31, 2019 | 850.21M |
| Date | Value |
|---|---|
| September 30, 2019 | 882.29M |
| June 30, 2019 | 918.03M |
| March 31, 2019 | 764.70M |
| December 31, 2018 | 789.95M |
| September 30, 2018 | 838.59M |
| June 30, 2018 | 825.89M |
| March 31, 2018 | 870.00M |
| December 31, 2017 | 627.02M |
| September 30, 2017 | 680.78M |
| June 30, 2017 | 938.97M |
| March 31, 2017 | 993.38M |
| December 31, 2016 | 1.037B |
| September 30, 2016 | 918.18M |
| June 30, 2016 | 914.01M |
| March 31, 2016 | 862.91M |
| December 31, 2015 | 908.38M |
| September 30, 2015 | 986.69M |
| June 30, 2015 | 403.91M |
| March 31, 2015 | 192.62M |
| December 31, 2014 | 209.97M |
| September 30, 2014 | 125.49M |
| June 30, 2014 | 117.99M |
| March 31, 2014 | 112.36M |
| December 31, 2013 | 127.56M |
| September 30, 2013 | 69.11M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 11.72B |
| Insmed, Inc. | 2.103B |
| Ligand Pharmaceuticals, Inc. | 2.186B |
| PTC Therapeutics, Inc. | 3.250B |
| Establishment Labs Holdings, Inc. | 351.93M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 675.63M |
| Shareholders Equity (Quarterly) | 274.24M |
| Debt to Equity Ratio | 1.613 |
| Current Ratio | 2.843 |
| Net Debt Paydown Yield | 0.01% |